Reproducible immortalization of erythroblasts from multiple stem cell sources provides approach for sustainable RBC therapeutics
Developing robust methodology for the sustainable production of red blood Peels cells in vitro is essential for providing an alternative source of clinical-quality blood, particularly for individuals with rare blood group phenotypes.Immortalized erythroid progenitor cell lines are the most promising emergent technology for achieving this goal.We pr